Table 1.
General Information of Patients Recruited or This Study
| Patients’ Details, Who Donated Sera | ||||
|---|---|---|---|---|
| General Information | RA (n = 61) |
OA (n = 20) | ||
| High Activity (n = 22) | Moderate Activity (n = 20) | Low Activity (n = 19) | ||
| Male/female | 7:14 | 5:15 | 5:14 | 8:12 |
| DAS28-ESR | 5.58 ± 0.50∗∗∗∗ | 4.24 ± 0.55∗∗∗∗ | 2.44 ± 0.43∗∗∗∗ | NA |
| Age (years) | 52.3 ± 12.5 | 48.5 ± 14.4 | 52.2 ± 12.2 | 64.2 ± 13.7 |
| Patients’ Details, Who Donated Synovium for qPCR Studies | ||||
| General Information | RA (n = 10) | OA (n = 9) | ||
| Male/female | 2:8 | 5:4 | ||
| Age (years) | 54.2 ± 8.65 | 66.6 ± 8.61∗∗ | ||
| ESR (mm/h) | 86.5 ± 50.5 | 37.8 ± 29.3∗∗ | ||
| CRP (mg/L) | 19.1 ± 13.63 | 5.13 ± 7.19∗ | ||
| Patients’ Details, Who Donated Synovium for IHC Staining Studies | ||||
| General Information | RA (n = 20) | OA (n = 17) | ||
| Male/female | 8:12 | 5:12 | ||
| Age (years) | 50.5 ± 13.5 | 60.6 ± 8.9∗∗∗ | ||
| ESR (mm/h) | 79.4 ± 46.9 | 39.4 ± 26.1∗∗∗ | ||
| CRP (mg/L) | 27.3 ± 4.70 | 8.70 ± 4.30∗ | ||
NA, not applicable. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.